查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1865418

全球營養基因體學檢測套組市場：預測至2032年－按組件、樣本類型、部署方法、測試類型、技術、應用和地區進行分析

Nutrigenomic Testing Kits Market Forecasts to 2032 - Global Analysis By Component, Sample Type, Deployment Mode, Test Type, Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球營養基因組學檢測套組市場預計到 2025 年將達到 6,690 萬美元，到 2032 年將達到 1.836 億美元，預測期內複合年成長率為 15.5%。

營養基因組學檢測套組分析個體的基因組成，以評估身體對特定營養素、飲食模式和生活方式因素的反應。透過檢測基因與營養素的相互作用，這些試劑盒能夠提供關於新陳代謝、食物敏感性和營養吸收的個人化見解。檢測結果指南制定個人化的營養和健康策略，旨在最佳化健康。營養基因組學檢測通常用於預防保健和個人化營養規劃，為符合個體獨特基因特徵和潛在易感性的實證飲食建議提供支持。

根據 2020 年發表在《營養素》（MDPI）雜誌上的一篇評論，全球消費者營養基因檢測市場估計有 250 多家公司，其中 100 多家公司提供基於基因譜的個性化飲食建議，這反映了基因營養策略的快速商業化和消費者日益成長的興趣。

越來越多的消費者希望獲得基於DNA的飲食建議。

利用基因檢測幫助人們了解自身營養代謝、食物敏感性以及根據基因量身定做的最佳飲食方案，正成為日益流行的趨勢。健康生活方式和預防性醫療保健策略的興起進一步推動了這一趨勢。數位平台和行動醫療應用程式正在擴大服務的可及性，使用戶能夠遠端獲得個人化的營養建議。隨著人們對基因與飲食之間相互作用的認知不斷加深，無論是在臨床管道還是面向消費者的管道，市場都呈現出消費者興趣激增的態勢。

臨床檢驗和標準化程度有限

許多試劑盒依賴尚未被監管機構或臨床醫生廣泛接受的新興研究。這種不確定性影響了消費者的信心，並限制了其融入主流醫療保健系統。此外，不同機構在實驗室調查方法和解讀框架上的差異也造成了混亂，阻礙了結果的可比較性。如果沒有可靠的臨床試驗和公認的指南，該市場可能被視為投機性強於實證醫學。

與預防保健計劃結合

營養基因組學檢測正日益成為預防性醫療保健框架中的積極工具。透過識別肥胖、糖尿病、心血管疾病等疾病的遺傳易感性，這些檢測試劑盒能夠實現早期飲食干預，從而降低長期健康風險。醫療保健機構和保險公司正在探索合作，將基因營養篩檢納入常規健康計畫。此外，企業健康計畫和健身平台也正在利用營養基因組學見解來改善個人化指導和飲食計畫。

科學懷疑論和錯誤訊息

批評者認為，許多基因與飲食的關聯仍未有定論或過度簡化，可能導致誤導。不準確的行銷宣傳和缺乏透明度的檢測結果解讀可能會損害消費者的信任。此外，未經監管的直接面對消費者（DTC）檢測套組的激增引發了人們對數據準確性和基因資訊倫理使用的擔憂。如果沒有透過嚴格的檢驗和清晰的溝通來解決這些問題，質疑聲音可能會減緩市場成長和監管核准。

新冠疫情的影響：

新冠疫情加速了人們對居家健康監測（包括基因營養檢測）的興趣。由於線下諮詢受限，消費者轉向遠距離診斷和個人化健康管理工具。人們希望透過個人化飲食來最佳化免疫力並控制慢性疾病，這導致對營養基因組學試劑盒的需求激增。然而，供應鏈中斷和檢查室能力下降暫時影響了試劑盒的供應和檢測結果的出具時間。

預計在預測期內，全EXOME/基因組檢測套組細分市場將佔據最大的市場佔有率。

由於其全面的基因覆蓋範圍和診斷深度，全EXOME/全基因組檢測套組盒預計將在預測期內佔據最大的市場佔有率。這些試劑盒能夠分析更廣泛的基因變異，深入了解營養代謝、疾病風險和飲食反應。其應用範圍涵蓋臨床營養、研究和個人化醫療，使其用途廣泛。定序技術和數據解讀的進步提高了檢測的準確性和可負擔性，進一步推動了此類試劑盒的普及。

預計在預測期內，藥物基因組學領域將實現最高的複合年成長率。

由於藥物基因組學在最佳化藥物-營養相互作用方面發揮重要作用，預計在預測期內，該領域將迎來最高的成長率。該領域專注於研究基因變異對個別藥物和補充劑反應的影響，從而製定更安全有效的治療方案。人們對膳食補充劑和機能性食品日益成長的興趣，推動了對藥物基因組學見解的需求，以指導個人化補充。與電子健康記錄和臨床決策支援系統的整合也進一步拓展了效用。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率，這得益於其完善的醫療保健基礎設施和較高的消費者意識。該地區受益於基因技術的早期應用、主要市場參與者的強大影響力以及有利的報銷政策。監管政策的明朗化和直接面對消費者（DTC）平台的廣泛應用進一步加速了市場滲透。此外，文明病的日益增加以及人們對預防性營養的日益關注，也推動了對個人化飲食解決方案的需求。生技公司與健康服務提供者之間的策略聯盟持續塑造區域市場格局。

預計年複合成長率最高的地區：

在預測期內，北美預計將實現最高的複合年成長率，這主要得益於醫療保健覆蓋範圍的擴大、可支配收入的增加以及人們對個性化健康日益成長的興趣。中國、印度和韓國等國在營養管理和慢性病管理方面，基因檢測的應用正不斷普及。政府推動數位健康和​​預防醫學的舉措，為市場擴張創造了有利條件。本土Start-Ups公司和國際公司都在投資開發適應不同文化背景的營養基因組學解決方案，以滿足多樣化的飲食習慣和基因特徵。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 技術分析
  • 應用分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球營養基因體學檢測套組市場（按組件分類）

  • 介紹
  • 基因型鑒定盒
  • 全外EXOME/基因組檢測套組
  • 生物標記組合
  • 軟體和報告平台
  • 配套行動應用
  • 其他部件

6. 全球營養基因體學檢測套組市場（依樣本類型分類）

  • 介紹
  • 唾液
  • 血
  • 頭髮
  • 口腔拭子
  • 其他樣本類型

7. 全球營養基因體學檢測套組市場依部署類型分類

  • 介紹
  • 直接面對消費者（DTC）
  • 臨床管理
  • 僅供研究使用 (RUO)
  • 藥局

8. 全球營養基因體檢測套組市場（依測試類型分類）

  • 介紹
  • 營養反應
  • 藥物基因體學
  • 微量營養素和維生素代謝
  • 體重管理和肥胖症小組
  • 健身、運動反應測試
  • 個人化補充劑推薦引擎
  • 其他類型的測試

9. 全球營養基因體學檢測套組市場（依技術分類）

  • 介紹
  • SNP基因基因型鑒定
  • 全基因組序列分析
  • 微陣列
  • 次世代定序
  • 其他技術

第10章 全球營養基因體檢測套組市場（按應用分類）

  • 介紹
  • 個人化營養和飲食計劃
  • 臨床營養支持
  • 體重管理計劃
  • 運動表現與運動員最佳化
  • 慢性病風險評估（糖尿病、心血管疾病）
  • 研究和臨床試驗
  • 其他用途

第11章 全球營養基因體學檢測套組市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：公司簡介

  • 23andMe
  • AncestryDNA
  • Nutrigenomix
  • DayTwo
  • Genova Diagnostics
  • Quest Diagnostics
  • Invitae
  • Myriad Genetics
  • Helix
  • LifeDNA
  • Viome
  • Onegevity
  • Atlas Biomed
  • Coral Genomics
  • Pathway Genomics
  • Medichecks
  • Biotronik
  • NIPD Genetics
  • Omixon
Product Code: SMRC32084

According to Stratistics MRC, the Global Nutrigenomic Testing Kits Market is accounted for $66.9 million in 2025 and is expected to reach $183.6 million by 2032 growing at a CAGR of 15.5% during the forecast period. Nutrigenomic testing kits analyze an individual's genetic makeup to assess how their body responds to specific nutrients, dietary patterns, and lifestyle factors. By examining gene-nutrient interactions, these kits provide personalized insights into metabolism, food sensitivities, and nutrient absorption. The results help guide tailored nutrition and wellness strategies aimed at optimizing health outcomes. Typically used in preventive healthcare and personalized nutrition planning, nutrigenomic testing supports evidence-based dietary recommendations aligned with an individual's unique genetic profile and potential predispositions.

According to a 2020 review published in Nutrients (MDPI), the global direct-to-consumer nutrigenetic testing market was estimated to exceed 250 companies, with over 100 offering personalized dietary recommendations based on genetic profiles, reflecting rapid commercialization and growing consumer interest in gene-based nutrition strategies.

Market Dynamics:

Driver:

Consumers increasingly seeking DNA-based dietary recommendations

Individuals are increasingly turning to genetic profiling to understand nutrient metabolism, food sensitivities, and optimal diet plans tailored to their unique genetic makeup. This trend is further supported by the rise of health-conscious lifestyles and preventive care strategies. Digital platforms and mobile health apps are amplifying accessibility, allowing users to receive customized nutrition advice remotely. As awareness of gene-diet interactions expands, the market is witnessing a surge in consumer interest across both clinical and direct-to-consumer channels.

Restraint:

Limited clinical validation and standardization

Many kits rely on emerging research that has yet to be universally accepted by regulatory bodies or clinical practitioners. This ambiguity affects consumer confidence and limits integration into mainstream healthcare. Moreover, variations in testing methodologies and interpretation frameworks across providers create confusion and hinder comparability. Without robust clinical trials and consensus guidelines, the market risks being perceived as speculative rather than evidence-based.

Opportunity:

Integration with preventive healthcare programs

Nutrigenomic testing is increasingly being positioned as a proactive tool within preventive healthcare frameworks. By identifying genetic predispositions to conditions like obesity, diabetes, and cardiovascular disease, these kits enable early dietary interventions that can mitigate long-term health risks. Healthcare providers and insurers are exploring partnerships to incorporate genetic nutrition screening into routine wellness programs. Additionally, corporate wellness initiatives and fitness platforms are adopting nutrigenomic insights to enhance personalized coaching and dietary planning.

Threat:

Scientific skepticism and misinformation

Critics argue that many genetic-diet associations are still inconclusive or oversimplified, leading to potential misinformation. Inaccurate marketing claims and lack of transparency in test interpretation can erode consumer trust. Furthermore, the proliferation of unregulated DTC kits raises concerns about data accuracy and ethical use of genetic information. If not addressed through rigorous validation and clear communication, skepticism may slow market growth and regulatory acceptance.

Covid-19 Impact:

The COVID-19 pandemic accelerated interest in home-based health monitoring, including genetic nutrition testing. With limited access to in-person consultations, consumers turned to remote diagnostics and personalized wellness tools. Nutrigenomic kits gained traction as individuals sought to optimize immunity and manage chronic conditions through tailored diets. However, supply chain disruptions and reduced laboratory capacity temporarily affected kit availability and turnaround times.

The whole exome/genome test kits segment is expected to be the largest during the forecast period

The whole exome/genome test kits segment is expected to account for the largest market share during the forecast period propelled by, its comprehensive genetic coverage and diagnostic depth. These kits analyze a broader range of genetic variants, enabling more detailed insights into nutrient metabolism, disease risk, and dietary response. Their application spans clinical nutrition, research, and personalized wellness, making them highly versatile. Technological advancements in sequencing and data interpretation are enhancing accuracy and affordability, further driving adoption.

The pharmacogenomics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmacogenomics segment is predicted to witness the highest growth rate, influenced by, its role in optimizing drug-nutrient interactions. This segment focuses on how genetic variations influence individual responses to medications and supplements, enabling safer and more effective therapeutic plans. Rising interest in nutraceuticals and functional foods is fueling demand for pharmacogenomic insights that guide personalized supplementation. Integration with electronic health records and clinical decision support systems is also expanding its utility in healthcare settings.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, fuelled by, by robust healthcare infrastructure and high consumer awareness. The region benefits from early adoption of genetic technologies, strong presence of key market players, and favorable reimbursement policies. Regulatory clarity and widespread availability of DTC platforms have further accelerated market penetration. Additionally, rising prevalence of lifestyle-related disorders and growing interest in preventive nutrition are driving demand for personalized dietary solutions. Strategic collaborations between biotech firms and wellness providers continue to shape the regional landscape.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, expanding healthcare access, rising disposable incomes, and growing interest in personalized wellness. Countries like China, India, and South Korea are witnessing increased adoption of genetic testing for nutrition and chronic disease management. Government initiatives promoting digital health and preventive care are creating fertile ground for market expansion. Local startups and international players are investing in culturally tailored nutrigenomic solutions, addressing diverse dietary habits and genetic profiles.

Key players in the market

Some of the key players in Nutrigenomic Testing Kits Market include 23andMe, AncestryDNA, Nutrigenomix, DayTwo, Genova Diagnostics, Quest Diagnostics, Invitae, Myriad Genetics, Helix, LifeDNA, Viome, Onegevity, Atlas Biomed, Coral Genomics, Pathway Genomics, Medichecks, Biotronik, NIPD Genetics, and Omixon.

Key Developments:

In October 2025, AncestryDNA launched its biggest ethnicity update to date. The update added 68 new European regions and re-analyzed all user DNA for improved accuracy. It now connects users to over 3,600 global ancestral locations.

In September 2025, Nutrigenomix partnered with Evexia Diagnostics to expand access to personalized nutrition testing. Clinicians can now offer DNA-based dietary recommendations backed by peer-reviewed science.

In September 2025, Myriad partnered with SOPHiA GENETICS to develop a liquid biopsy companion diagnostic. This collaboration targets precision oncology using real-time genomic insights.

Components Covered:

  • Genotyping Kits
  • Whole Exome/Genome Test Kits
  • Biomarker Panels
  • Software & Reporting Platforms
  • Companion Mobile Apps
  • Other Components

Sample Types Covered:

  • Saliva
  • Blood
  • Hair
  • Buccal Swab
  • Other Sample Types

Deployment Modes Covered:

  • Direct-to-Consumer (DTC)
  • Clinically Administered
  • Research-Use-Only (RUO)
  • Pharmacy

Test Types Covered:

  • Nutrition Response
  • Pharmacogenomics
  • Micronutrient & Vitamin Metabolism
  • Weight Management & Obesity-related Panels
  • Fitness & Exercise Response Tests
  • Personalized Supplement Recommendation Engines
  • Other Test Types

Technologies Covered:

  • SNP Genotyping
  • Whole Genome Sequencing
  • Microarray
  • Next-Generation Sequencing
  • Other Technologies

Applications Covered:

  • Personalized Nutrition & Diet Planning
  • Clinical Nutrition Support
  • Weight Management Programs
  • Sports Performance & Athlete Optimization
  • Chronic Disease Risk Assessment (diabetes, CVD)
  • Research & Clinical Trials
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nutrigenomic Testing Kits Market, By Component

  • 5.1 Introduction
  • 5.2 Genotyping Kits
  • 5.3 Whole Exome/Genome Test Kits
  • 5.4 Biomarker Panels
  • 5.5 Software & Reporting Platforms
  • 5.6 Companion Mobile Apps
  • 5.7 Other Components

6 Global Nutrigenomic Testing Kits Market, By Sample Type

  • 6.1 Introduction
  • 6.2 Saliva
  • 6.3 Blood
  • 6.4 Hair
  • 6.5 Buccal Swab
  • 6.6 Other Sample Types

7 Global Nutrigenomic Testing Kits Market, By Deployment Mode

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (DTC)
  • 7.3 Clinically Administered
  • 7.4 Research-Use-Only (RUO)
  • 7.5 Pharmacy

8 Global Nutrigenomic Testing Kits Market, By Test Type

  • 8.1 Introduction
  • 8.2 Nutrition Response
  • 8.3 Pharmacogenomics
  • 8.4 Micronutrient & Vitamin Metabolism
  • 8.5 Weight Management & Obesity-related Panels
  • 8.6 Fitness & Exercise Response Tests
  • 8.7 Personalized Supplement Recommendation Engines
  • 8.8 Other Test Types

9 Global Nutrigenomic Testing Kits Market, By Technology

  • 9.1 Introduction
  • 9.2 SNP Genotyping
  • 9.3 Whole Genome Sequencing
  • 9.4 Microarray
  • 9.5 Next-Generation Sequencing
  • 9.6 Other Technologies

10 Global Nutrigenomic Testing Kits Market, By Application

  • 10.1 Introduction
  • 10.2 Personalized Nutrition & Diet Planning
  • 10.3 Clinical Nutrition Support
  • 10.4 Weight Management Programs
  • 10.5 Sports Performance & Athlete Optimization
  • 10.6 Chronic Disease Risk Assessment (diabetes, CVD)
  • 10.7 Research & Clinical Trials
  • 10.8 Other Applications

11 Global Nutrigenomic Testing Kits Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 23andMe
  • 13.2 AncestryDNA
  • 13.3 Nutrigenomix
  • 13.4 DayTwo
  • 13.5 Genova Diagnostics
  • 13.6 Quest Diagnostics
  • 13.7 Invitae
  • 13.8 Myriad Genetics
  • 13.9 Helix
  • 13.10 LifeDNA
  • 13.11 Viome
  • 13.12 Onegevity
  • 13.13 Atlas Biomed
  • 13.14 Coral Genomics
  • 13.15 Pathway Genomics
  • 13.16 Medichecks
  • 13.17 Biotronik
  • 13.18 NIPD Genetics
  • 13.19 Omixon

List of Tables

  • Table 1 Global Nutrigenomic Testing Kits Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Nutrigenomic Testing Kits Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Nutrigenomic Testing Kits Market Outlook, By Genotyping Kits (2024-2032) ($MN)
  • Table 4 Global Nutrigenomic Testing Kits Market Outlook, By Whole Exome/Genome Test Kits (2024-2032) ($MN)
  • Table 5 Global Nutrigenomic Testing Kits Market Outlook, By Biomarker Panels (2024-2032) ($MN)
  • Table 6 Global Nutrigenomic Testing Kits Market Outlook, By Software & Reporting Platforms (2024-2032) ($MN)
  • Table 7 Global Nutrigenomic Testing Kits Market Outlook, By Companion Mobile Apps (2024-2032) ($MN)
  • Table 8 Global Nutrigenomic Testing Kits Market Outlook, By Other Components (2024-2032) ($MN)
  • Table 9 Global Nutrigenomic Testing Kits Market Outlook, By Sample Type (2024-2032) ($MN)
  • Table 10 Global Nutrigenomic Testing Kits Market Outlook, By Saliva (2024-2032) ($MN)
  • Table 11 Global Nutrigenomic Testing Kits Market Outlook, By Blood (2024-2032) ($MN)
  • Table 12 Global Nutrigenomic Testing Kits Market Outlook, By Hair (2024-2032) ($MN)
  • Table 13 Global Nutrigenomic Testing Kits Market Outlook, By Buccal Swab (2024-2032) ($MN)
  • Table 14 Global Nutrigenomic Testing Kits Market Outlook, By Other Sample Types (2024-2032) ($MN)
  • Table 15 Global Nutrigenomic Testing Kits Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 16 Global Nutrigenomic Testing Kits Market Outlook, By Direct-to-Consumer (DTC) (2024-2032) ($MN)
  • Table 17 Global Nutrigenomic Testing Kits Market Outlook, By Clinically Administered (2024-2032) ($MN)
  • Table 18 Global Nutrigenomic Testing Kits Market Outlook, By Research-Use-Only (RUO) (2024-2032) ($MN)
  • Table 19 Global Nutrigenomic Testing Kits Market Outlook, By Pharmacy (2024-2032) ($MN)
  • Table 20 Global Nutrigenomic Testing Kits Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 21 Global Nutrigenomic Testing Kits Market Outlook, By Nutrition Response (2024-2032) ($MN)
  • Table 22 Global Nutrigenomic Testing Kits Market Outlook, By Pharmacogenomics (2024-2032) ($MN)
  • Table 23 Global Nutrigenomic Testing Kits Market Outlook, By Micronutrient & Vitamin Metabolism (2024-2032) ($MN)
  • Table 24 Global Nutrigenomic Testing Kits Market Outlook, By Weight Management & Obesity-related Panels (2024-2032) ($MN)
  • Table 25 Global Nutrigenomic Testing Kits Market Outlook, By Fitness & Exercise Response Tests (2024-2032) ($MN)
  • Table 26 Global Nutrigenomic Testing Kits Market Outlook, By Personalized Supplement Recommendation Engines (2024-2032) ($MN)
  • Table 27 Global Nutrigenomic Testing Kits Market Outlook, By Other Test Types (2024-2032) ($MN)
  • Table 28 Global Nutrigenomic Testing Kits Market Outlook, By Technology (2024-2032) ($MN)
  • Table 29 Global Nutrigenomic Testing Kits Market Outlook, By SNP Genotyping (2024-2032) ($MN)
  • Table 30 Global Nutrigenomic Testing Kits Market Outlook, By Whole Genome Sequencing (2024-2032) ($MN)
  • Table 31 Global Nutrigenomic Testing Kits Market Outlook, By Microarray (2024-2032) ($MN)
  • Table 32 Global Nutrigenomic Testing Kits Market Outlook, By Next-Generation Sequencing (2024-2032) ($MN)
  • Table 33 Global Nutrigenomic Testing Kits Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 34 Global Nutrigenomic Testing Kits Market Outlook, By Application (2024-2032) ($MN)
  • Table 35 Global Nutrigenomic Testing Kits Market Outlook, By Personalized Nutrition & Diet Planning (2024-2032) ($MN)
  • Table 36 Global Nutrigenomic Testing Kits Market Outlook, By Clinical Nutrition Support (2024-2032) ($MN)
  • Table 37 Global Nutrigenomic Testing Kits Market Outlook, By Weight Management Programs (2024-2032) ($MN)
  • Table 38 Global Nutrigenomic Testing Kits Market Outlook, By Sports Performance & Athlete Optimization (2024-2032) ($MN)
  • Table 39 Global Nutrigenomic Testing Kits Market Outlook, By Chronic Disease Risk Assessment (diabetes, CVD) (2024-2032) ($MN)
  • Table 40 Global Nutrigenomic Testing Kits Market Outlook, By Research & Clinical Trials (2024-2032) ($MN)
  • Table 41 Global Nutrigenomic Testing Kits Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.